For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Treatment of drugs for regulating rheumatic diseases
Scope of the Report:
Rheumatic diseases are a series of diseases characterized by chronic pain. Some of the most common diseases are osteoarthritis (OA) and rheumatoid arthritis (RA), and most rheumatic diseases use basically universal pain control drugs. Treatment is ongoing and there are no treatments for any of the key indications, so there is a need to develop better disease modulating drugs.
The global Rheumatic Disorders Drug market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Rheumatic Disorders Drug.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Rheumatic Disorders Drug market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Rheumatic Disorders Drug market by product type and applications/end industries.
Market Segment by Companies, this report covers
- AbbVie
- Amgen
- Johnson & Johnson
- Novartis
- Pfizer
- Roche
- Eli Lilly
- Bristol-Myers Squibb
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Acting on Tumor Necrosis Factor-Alpha
- Acting on Interleukins and Interleukin Receptors
- Acting on Protein Kinases
- Acting on Cell Surface Antigens
- Acting on Hormones and Hormone Receptors
- Others
Market Segment by Applications, can be divided into
- Rheumatoid Arthritis
- Osteoarthritis
- Osteoporosis
- Systemic Lupus Erythematosus
- Psoriatic Arthritis
- Others